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The increasing interest for hadrontherapy can be attributed 
to the great accuracy of ion beams to target the tumor while 
sparing the surrounding healthy tissues (due to the high dose 
deposition in the Bragg peak and the small angular scattering 
of ions) as well as the potential biological advantage of ions 
for some tumor types compared to photons. 
To keep the benefits of carbon ions in radiotherapy, a very 
high accuracy on the dose location is required. The dose 
deposition is affected by the fragmentation of the incident 
ions that leads to: (i) the consumption of the projectiles with 
their penetration depth in the tissues, (ii) the creation of 
lighter fragments having a different biological effectiveness 
(RBE), (iii) the apparition of a fragmentation tail after the 
tumor. The constraints on nuclear models and/or 
fragmentation cross sections in the energy range used in 
hadrontherapy (up to 400 MeV/n) are not yet sufficient to 
reproduce the local dose deposition with the accuracy 
required in a clinical treatment. 
In this context, two experiments with 95 MeV/n 12C beams 
have been performed by our collaboration in 2011 and 2013 
at GANIL [1,2] to measure the energy and angular  
differential fragmentation cross sections on thin targets of 
medical interest (H, C, Al, O and natTi). In March 2015, a new 
experiment with a 50 MeV/n 12C beam on the same targets 
has been conducted at GANIL. The experimental set-up was 
made of five three stages  telescopes, each composed of two 
Si detectors and one CsI scintillator mounted on rotating 
stages to cover angles from 3° to 39°. 
The analysis of this new experiment is under completion. It 
shows that the angular cross sections for light fragments are 
less forward-focused at 50 MeV/n compared to 95 MeV/n, 
resulting in “flatter” distributions. As shown in Figure 1, 
protons and 4He fragments are dominant on the entire 
angular distribution. At this beam energy, the production of 
alpha particles is higher than protons for angles up to 20° 
compared to 10° at 95 MeV/n. 
However, at the most forward angles, 11B fragments seem to 
compete with the protons production. 
The energy distributions of the fragments at forward angles 
are peaked close to the beam energy showing an emission 
dominated by the quasi-projectile. Comparisons between 
experimental data and Geant4 simulations using different 
inelastic models (such as BIC, QMD and INCL++) show 
important discrepancies. 
Final data as well as comparisons with simulations and the 
previous experiments will be presented during the 
conference. 
 
 
Figure 2: Preliminary angular differential cross section for 
various isotopes, from Z=1 to Z=5 
 
Keywords: Hadrontherapy, Nuclear-Fragmentation, Cross-
Sections 
 
References: 
[1] J. Dudouet et al. Physical Review C 88, 024606 (2013) 
[2] J. Dudouet et al. Physical Review C 89, 064615 (2014)  
 
68 
Correlation of Particle Traversals with Clonogenic Survival 
Using Cell-Fluorescent Ion Track Hybrid Detector 
I. Dokic1,2,3, M. Niklas1,2,3, F. Zimmermann1,2,3, A. Mairani2,4, P. 
Seidel1,2,3, D. Krunic5, O. Jäkel1,2,6, J. Debus1,2,3, S. Greilich1,6, 
A. Abdollahi1,2,3 
1 German Cancer Consortium (DKTK), Translational Radiation 
Oncology, National Center for Tumor Diseases (NCT), 
Heidelberg Institute of Radiation Oncology (HIRO), German 
Cancer Research Center (DKFZ), Heidelberg, Germany 
2 Heidelberg Ion Therapy Center (HIT), Heidelberg, Germany 
3 Department of Radiation Oncology, Heidelberg University 
Hospital, Heidelberg, Germany 
4 National Center for Oncological Hadrontherapy (CNAO), 
Pavia, Italy 
5 Light Microscopy Facility, German Cancer Research Center, 
Heidelberg, Germany 
6 Division of Medical Physics in Radiation Oncology, German 
Cancer Research Center, Germany 
 
Purpose: In radiobiology, the clonogenic survival of cells is 
considered the gold standard assay for assessment of cellular 
sensitivity to ionizing radiation. Towards further 
development of next generation biodosimeters in particle 
therapy, cell-fluorescent ion track hybrid detector (Cell-FIT-
HD) previously engineered by our group 1, 2 was utilized to 
study its feasibility as a tool for investigating the effects of 
clinical beams on cellular clonogenic survival. 
Materials and methods: Tumor cells were grown on the 
fluorescent nuclear track detector (FNTD) in cell culture, 
mimicking the standard procedures for clonogenic assay. 
Cell-FIT-HD was used to detect the spatial distribution of 
particle tracks within colony-initiating cells. The physical 
data were associated to radiation induced foci as surrogates 
for DNA double strand breakages (DSB), the hallmark of 
radiation -induced cell lethality. Long-term cell fate was 
monitored to determine the ability of cells to form colonies.  
Results and conclusion:  We showed that single cells can 
attach and grow as colonies on FNTD surface. Usage of the 
fluorescent and confocal microscopy, together with FNTD 
technology, enabled simultaneous analysis of the microscopic 
beam parameters together with the molecular events within 
colonies, at sub-cellular level.   We report the first successful 
